3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Squamous Cell Carcinoma of Head and Neck
618
Head and Neck Neoplasms
599
Nasopharyngeal Carcinoma
230
Thyroid Neoplasms
148
Oropharyngeal Neoplasms
104
Carcinoma, Squamous Cell
90
Salivary Gland Neoplasms
88
Mouth Neoplasms
87
Nasopharyngeal Neoplasms
79
Recurrence
66
Carcinoma, Non-Small-Cell Lung
66
Laryngeal Neoplasms
60
Neoplasm Metastasis
58
Neoplasms
49
Hypopharyngeal Neoplasms
45
Thyroid Carcinoma, Anaplastic
42
Thyroid Cancer, Papillary
42
Melanoma
38
Breast Neoplasms
36
Lung Neoplasms
34
Adenocarcinoma, Follicular
33
Carcinoma
32
Tongue Neoplasms
30
Sarcoma
29
Uterine Cervical Neoplasms
28
Stomatitis
28
Colorectal Neoplasms
28
Carcinoma, Medullary
24
Ovarian Neoplasms
23
Esophageal Neoplasms
23
Interventions
trametinib
1
dabrafenib
1
Thyrotropin Alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
×
Head & Neck
×
Clear all
NCT03244956
2026-03-23
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
Completed
40 enrolled